- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04899609
The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers
Behavioral Adaptation to Negative and Positive Social Signals in Healthy Volunteers
Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus would cause a conditioned response (innate reaction). Thus, the presence of an angry person would automatically trigger flight behavior. More recently, however, it has been envisioned that this same avoidance behavior could be the result of a goal-directed behvior. In this case, the avoidance behavior would be the result of an evaluation of the consequences of the selected action. These goal-directed behaviors are guided by a mental representation of consequences The project aims to study behavioral choices (approach and avoidance) in response to negative and positive social cues (anger and joy) in 40 healthy volunteers using a computerized neuropsychological task, and to determine wheter these choices are the result of goal-directed behavior.
The study also aims to assess the modulation of behavioral adaptation by the level of impulsivity, lonilness, empathy, and by the capcity to understand others' intenstions.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Emilie OLIE, MD PhD
- Phone Number: +33 4 67 33 85 81
- Email: e-olie@chu-montpellier.fr
Study Contact Backup
- Name: Nathan RISCH, MD (intern)
- Email: risch.nathan@gmail.com
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- University Hospital
-
Contact:
- Emilie OLIE, MD PhD
- Phone Number: 33 4 67 33 82 89
- Email: e-olie@chu-montpellier.fr
-
Contact:
- Myriam BENRAMDANE
- Phone Number: 33 4 99 61 45 75
- Email: m-benramdane@chu-montpellier.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Being between 18 and 65 years old
- Absence of psychiatric pathology over the entire life
- Being able to understand the nature, purpose and methodology of the study
Exclusion criteria:
- Mental retardation or sever medical co-morbidity
- Sensory or cognitive disability
- Pregnant or breastfeeding woman
- Protection by law (guardianship or curatorship)
- Deprivation of liberty (by judicial or administrative decision)
- Exclusion period in relation to another protocol
- Inability to understand, speak and write French
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of approach and avoidance behavior in response to positive (joy) and negative (anger) social signals
Time Frame: 1 day
|
Calculation of the proportion of avoidance vs. approach choices
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response time
Time Frame: 1 day
|
Computerized measurement of reaction time before clicking to make the avoidance or approach choice
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Emilie Olie, MD PhD, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RECHMPL21_0304
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Episode
-
Northside Clinic, AustraliaWesley MissionCompletedMajor Depressive EpisodeAustralia
-
Medical University of ViennaUnknownMajor Depressive EpisodeAustria
-
The University of New South WalesWesley MissionUnknown
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Jiangsu Province Nanjing Brain HospitalRecruitingMajor Depressive EpisodeChina
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
University Medical Center GoettingenCompletedMajor Depressive Disorder | Depressive EpisodeGermany
-
University of British ColumbiaRecruitingMajor Depressive Disorder | Major Depressive EpisodeCanada
-
Weill Medical College of Cornell UniversityUnknownMajor Depressive Disorder | Major Depressive EpisodeUnited States
-
University of British ColumbiaCentre for Addiction and Mental HealthRecruitingDepression | Major Depressive Disorder | Major Depressive EpisodeCanada